Monte Rosa Therapeutics

Monte Rosa Therapeutics: Clinical Stage, next-generation molecular glue-based targeted protein degradation platform developing small molecule therapeutics that selectively degrade disease-causing proteins. AI-based degron prediction targets the undruggable proteome in both oncology and other disease areas. Extensive preclinical data demonstrating potent anti-tumor activity. Lead asset MRT-2359 targeting degradation of GSPT1 and dosed first patient in 4Q22 in a Phase 1/2 study in patients with MYC-driven solid tumors, including lung cancer.
Based in...
Europe, US - New England
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Platform Technology, Protein Degradation
Klybeckstrasse 191
Basel, Basel-Stadt

Company Participants at Solebury Trout 1x1 Management Access Event 2022

  • Markus Warmuth, CEO

Top 10 Holders of Monte Rosa Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
NEA Management Co. 15.89 7,692,298 55.54 13F 12/31/22
Fidelity Management & Research Co. LLC 10.00 4,838,091 34.93 13F 12/31/22
Avoro Capital Advisor LLC 8.94 4,325,000 31.23 13F 12/31/22
T. Rowe Price Associates, Inc. (Investment Management) 7.61 3,683,430 26.59 13F 12/31/22
Cormorant Asset Management LP 5.98 2,893,717 20.89 13F 12/31/22
T. Rowe Price Investment Management, Inc. 4.00 1,934,539 13.97 13F 12/31/22
HBM Partners AG (Investment Management) 3.33 1,609,633 11.62 Funds 12/31/22
Aisling Capital Management LP 3.04 1,472,331 10.63 13F 12/31/22
Alphabet, Inc. 3.02 1,464,015 10.57 13F 12/31/22
The Vanguard Group, Inc. 2.89 1,399,354 10.10 Funds 2/28/23
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.